These final results, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the notion of focusing on ACKR3 as a novel technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Diseases. Howdy. I just https://michaelm132shu0.blogripley.com/profile